Details of the Drug-Related molecule(s) Interaction Atlas
General Information of Drug (ID: DM8E9YS)
Drug Name | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
ATAGABALIN; 223445-75-8; UNII-JT7957Q2FB; CHEMBL593430; JT7957Q2FB; PD-0200390; 2-[(3S,4S)-1-(aminomethyl)-3,4-dimethylcyclopentyl]acetic acid; trans-dimethyl gababutin; Atagabalin [USAN:INN]; 2-((3S,4S)-1-(Aminomethyl)-3,4-dimethylcyclopentyl)acetic acid; Atagabalin (USAN/INN); SCHEMBL121610; CTK1A0230; BDBM50305887; AKOS030591721; DB12032; AN-5147; CS-0003598; PD 0200390; D09581; ((3S,4S)-1-(Aminomethyl)-3,4-dimethylcyclopentyl)acetic acid; 3,4-trans-2-(1-(aminomethyl)-3,4-dimethylcyclopentyl)acetic acid
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecule-Related Drug Atlas
Molecule-Related Drug Atlas
Molecule Type:
DTT Drug Status:
Approved Drug(s) Clinical Trial Drug(s) Discontinued Drug(s) Investigative Drug(s) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Drug(s) Targeting Voltage-gated calcium channel alpha-2/delta-1 (CACNA2D1)
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Molecular Interaction Atlas | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
References